Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why GenMark Stock Soared Today

TheMotleyFool

0 0

Shares of GenMark Diagnostics (NASDAQ: GNMK) surged 29.6% on Monday after the molecular testing company said it has agreed to a merger with Swiss pharmaceutical giant Roche Holding (OTC: RHHBY).

Roche will conduct a tender offer to acquire all of GenMark's outstanding stock for $24.05 per share, a roughly 43% premium to the price at which its shares were trading before rumors of the merger emerged back in February. The all-cash deal values GenMark at roughly $1.8 billion. It's expected to close in the second quarter.

GenMark and Roche agreed to a merger on Monday. Image source: Getty Images.

Source Fool.com

Like: 0

GNMK

Share